- Home
- Publications
- Publication Search
- Publication Details
Title
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia
Authors
Keywords
-
Journal
ANNALS OF PHARMACOTHERAPY
Volume 50, Issue 12, Pages 1051-1059
Publisher
SAGE Publications
Online
2016-08-13
DOI
10.1177/1060028016664361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2015) Justin B. Usery et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- ReducedIn VitroActivity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia
- (2015) I. J. Abbott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Neutropenia Associated with Long-Term Ceftaroline Use
- (2015) Katherine W. LaVie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Activity against Bacterial Pathogens Frequently Isolated in U.S. Medical Centers: Results from Five Years of the AWARE Surveillance Program
- (2015) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Large Retrospective Evaluation of the Effectiveness and Safety of Ceftaroline Fosamil Therapy
- (2014) A. M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy
- (2014) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
- (2014) George Sakoulas et al. CLINICAL THERAPEUTICS
- Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations
- (2014) Joseph A. Paladino et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Management ofStaphylococcus aureusBacteremia
- (2014) Thomas L. Holland et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Salvage treatment of methicillin-resistant staphylococcal endocarditis with ceftaroline: a multicentre observational study
- (2014) P. Tattevin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline
- (2014) Rupali Jain et al. PHARMACOTHERAPY
- Ceftaroline in Combination With Trimethoprim-Sulfamethoxazole for Salvage Therapy of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis
- (2014) Valeria Fabre et al. Open Forum Infectious Diseases
- Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To EvaluateIn VitroSusceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae
- (2013) Scott A. Van Wart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future
- (2013) K. A. Rodvold et al. CLINICAL INFECTIOUS DISEASES
- Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: Taking advantage of the back door left open?
- (2013) Jessica K. Ortwine et al. DRUG RESISTANCE UPDATES
- Current and prospective treatments for multidrug-resistant gram-positive infections
- (2013) Jeffrey M Rybak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature
- (2013) Hari M. Polenakovik et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report
- (2013) K. Jongsma et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients
- (2012) Jennifer C. Lin et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Ceftaroline Fosamil: A Novel Broad-Spectrum Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus
- (2011) Margaret R Jorgenson et al. ANNALS OF PHARMACOTHERAPY
- Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
- (2011) Marin L Schweizer et al. BMC INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile Neutropenic Patients with Mild Impairment of Renal Function
- (2010) F. Lamoth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
- (2010) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study
- (2010) E. Goldberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model
- (2009) C. Vidaillac et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
- (2009) Pamela A Moise et al. LANCET INFECTIOUS DISEASES
- Waves of resistance: Staphylococcus aureus in the antibiotic era
- (2009) Henry F. Chambers et al. NATURE REVIEWS MICROBIOLOGY
- Management of Methicillin‐ResistantStaphylococcus aureusBacteremia
- (2008) Sara E. Cosgrove et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now